Managed Healthcare Executive January 27, 2023
Results from a recent U.S. Department of Health and Human Services (HHS) analysis shared that Medicare beneficiaries who use insulin would have saved $734 million in Part D and $27 million in Part B if these caps had been in effect in 2020
Medicare beneficiaries with diabetes are now on a path to potentially save millions in out-of-pocket costs on insulin this year under the Inflation Reduction Act (IRA). This massive savings certainly would have been true in 2020, as out-of-pocket costs for insulin under Medicare are currently capped at $35 per monthly prescription for part D enrollees.
Results from a recent U.S. Department of Health and Human Services (HHS) analysis shared that Medicare beneficiaries who use insulin would have...
Today's Sponsors
Today's Sponsor